scholarly journals A Case of Carcinoma of the Transverse Colon with Duodenocolic Fistula with Long-term Survival after En Bloc Radical Surgery

2013 ◽  
Vol 74 (8) ◽  
pp. 2228-2233
Author(s):  
Hiroki UEDA ◽  
Naoaki HOSHINO ◽  
Hitoshi SUGIMOTO ◽  
Ito KONDO ◽  
Chihiro ONO ◽  
...  
Author(s):  
Hiroshi OKAMOTO ◽  
Yuko ITAKURA ◽  
Kenichi YOKOTA ◽  
Wataru ENDO ◽  
Hironobu SASANO

2020 ◽  
Author(s):  
Yun-Xiao Zhang ◽  
Dong-Liang Mu ◽  
Ke-Min Jin ◽  
Xue-Ying Li ◽  
Dong-Xin Wang

Abstract Background Perioperative anesthetic management may affect long-term outcome after cancer surgery. This study aimed to investigate the effect of perioperative glucocorticoids on long-term survival in patients after radical resection for pancreatic cancer.Methods In this retrospective cohort study, patients who underwent radical resection for pancreatic cancer from January 2005 to December 2016 were recruited. Baseline and perioperative data including use of glucocorticoids for prevention of postoperative nausea and vomiting were collected. Patients were followed up for tumor recurrence and survival. The primary outcome was the overall survival (OS); the secondary outcome was the recurrence-free survival (RFS). A multivariable Cox proportional hazard model was used to analyze the influence of perioperative glucocorticoid use on OS and RFS after correction for confounding factors.Results A total of 215 patients after radical surgery for pancreatic cancer were included in the study; of these, 112 received perioperative glucocorticoids and 103 did not. Patients were followed up for a median of 74.0 months (95% confidence interval [CI] 68.3-79.7). Both OS and RFS were significantly longer in patients with glucocorticoids than in those without (for OS: median 19.7 months [95% CI 12.3-36.2] vs. 13.9 months [8.0-23.9], P=0.001; for RFS: 12.0 months [6.0-28.0] vs. 6.9 months [4.2-17.0], P=0.002). After correction for confounding factors, perioperative glucocorticoids were significantly associated with prolonged OS (HR 0.692, 95% CI 0.499-0.959, P=0.027) and RFS (HR 0.634, 95% CI 0.459-0.878, P=0.006).Conclusions Perioperative use of low-dose glucocorticoids may improve long-term survival in patients undergoing radical surgery for pancreatic cancer.


2018 ◽  
Vol 150 (1) ◽  
pp. 44-49 ◽  
Author(s):  
Jill H. Tseng ◽  
Alessia Aloisi ◽  
Yukio Sonoda ◽  
Ginger J. Gardner ◽  
Oliver Zivanovic ◽  
...  

2019 ◽  
Vol 07 (06) ◽  
pp. E733-E742 ◽  
Author(s):  
Andres Mora ◽  
Kenro Kawada ◽  
Yasuaki Nakajima ◽  
Takuya Okada ◽  
Yutaka Tokairin ◽  
...  

Abstract Background and study aims Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are promising therapeutic options for early esophageal cancer (EC). The factors that can affect mid- and long-term survival in patients with submucosal EC (SM1 and SM2) have not been described in the literature. We aim to describe clinicopathological outcomes and factors that can affect the mid- and long-term survival in patients with resected submucosal tumors. Patients and methods We performed a retrospective analysis of patients who underwent endoscopic resection (ER) for submucosal tumors over a 20-year period. The final study population included 119 cases with 137 lesions. Information was collected according to the Japanese Classification of Esophageal Cancer 11-edition and factors affecting survival for 2 and 5 years after ER were analyzed. Results EMR was performed in 99 cases (72.3 %), ESD in 38 cases (27.7 %). There were no significant complications. Two- and 5-year survival rates were 91 % and 82 %, respectively. Mean age was 67.22 years (± 9.49 years), mortality caused by EC occurred in 13 cases (11 %). Factors that had a significant impact on long-term survival were age > 65 years (P = 0.0026), number of resected specimens (P = 0.0031), presence of another progressive disease (not EC) (P ≤ 0.001), recurrence (P = 0.0002), and relation between histopathological positive vertical margin and recurrence (P = 0.0112). Conclusions ER is viable treatment for esophageal submucosal cancer, selection between ESD/EMR can depend on tumor size and patient condition, and en bloc ER is the recommended technique for submucosal tumors. Long-term survival factors were identified.


1980 ◽  
Vol 14 (4) ◽  
pp. 389-394 ◽  
Author(s):  
Joel M. Goldman ◽  
Elihu N. Goren ◽  
Max H. Cohen ◽  
Bruce L. Webber ◽  
Murray F. Brennan ◽  
...  

2008 ◽  
Vol 51 (10) ◽  
pp. 1548-1551 ◽  
Author(s):  
Akio Saiura ◽  
Junji Yamamoto ◽  
Masashi Ueno ◽  
Rintaro Koga ◽  
Makoto Seki ◽  
...  

2012 ◽  
Vol 111 (3b) ◽  
pp. E59-E64 ◽  
Author(s):  
Jan Dominik ◽  
Petr Moravek ◽  
Pavel Zacek ◽  
Jan Vojacek ◽  
Miroslav Brtko ◽  
...  

2021 ◽  
Author(s):  
Linlin Yin ◽  
Haihao Yan ◽  
Jue Lin ◽  
Zuhong Ji ◽  
Guozhong Ji ◽  
...  

Abstract Surgical resection is the first choice for the treatment of small intestinal gastrointestinal stromal tumors (GISTs), but the best surgical method for small intestinal stromal tumors remains undefined. It is not clear whether there is a difference in the long-term survival of small intestinal GISTs between radical surgery and non-radical surgery. We included 877 patients with small intestinal stromal tumors who underwent surgery between 2010 and 2015 from the SEER database. They were divided into the radical resection group and the non-radical resection group. To minimized the selection bias and mixed bias in the comparison, propensity score matching (PSM) and multivariate regression analysis were carried out. In the entire cohort, 120 patients underwent radical surgery and 757 patients received non-radical resection. The 1, 3, and 5-year OS rates were 95.7%, 80.2%, and 69.6% in the radical resection group versus 94.3%, 86.8%, and 77.2% in the non-radical resection group, respectively. (p=0.069) Meanwhile, radical resection had the similar CSS rates of 1, 3 and 5-year compared with non-radical surgery. (1-year CSS rate: 97.4% vs. 98.0%, 3-year CSS rate: 86.1% vs. 93.2%, 5-year CSS rate: 81.6% vs. 88.3%; p =0.056) Besides, after adjusting for other clinical factors and PSM, the long-term OS and CSS did not significantly differ between radical surgery and non-radical surgery. Our study preliminarily found that for small intestinal GISTs, there was no significant difference in long-term survival between radical surgery and non-radical surgery.


Sign in / Sign up

Export Citation Format

Share Document